Stock data
United Therapeutics Corporation (UTHR)
United Therapeutics Corporation (UTHR) reported revenue of US$3.18B and net income of US$1.33B for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$3.18B | US$2.80B | US$1.49B | US$1.33B | — |
| 2024 | US$2.88B | US$2.57B | US$1.38B | US$1.20B | — |
| 2023 | US$2.33B | US$2.07B | US$1.18B | US$984.80M | — |
| 2022 | US$1.94B | US$1.78B | US$979.70M | US$727.30M | — |
| 2021 | US$1.69B | US$1.56B | US$555.90M | US$475.80M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$783.30M | US$333.00M | — |
| 2026-03-31 | US$781.50M | US$274.90M | — |
| 2025-12-31 | US$790.20M | US$364.30M | — |
| 2025-09-30 | US$799.50M | US$338.70M | — |
| 2025-06-30 | US$798.60M | US$309.50M | — |
| 2025-03-31 | US$794.40M | US$322.20M | — |
| 2024-12-31 | US$735.90M | US$301.30M | — |
| 2024-09-30 | US$748.90M | US$309.10M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.